Cabaletta Bio Inc (CABA) Stock Forecast & Price Target
Cabaletta Bio Inc · NASDAQ
$2.73+0.04 (+1.30%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Cabaletta Bio Inc, 5 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. The target range is very wide, $4.00 to $30.00 (about 7.5x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $14.83 sits 444% above the current $2.73. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.31 next quarter toward $-1.42 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Moderate Buy
Strong Buy00%
Buy583%
Hold117%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Cabaletta Bio Inc.
As of Jul, 5 of 6 firms rate CABA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CABA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.31
Range $-0.42 – $-0.20 · 5 analysts · -28% YoY
Next period, 5 analysts expect Cabaletta Bio Inc to earn $-0.31 a share (range $-0.42 – $-0.20), versus $-0.44 a year earlier. Full-year consensus is $-1.34, growing to $-1.42 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 5 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $0 next year.
Top analysts covering Cabaletta Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CABA.
#1
Yatin Suneja
Guggenheim · Rank #28
Buy
$16.00+487.2% to target
Overall win rate
52%
+ Follow
#2
Josh Schimmer
Cantor Fitzgerald · Rank #140
Buy
$30.00+1000.9% to target
Overall win rate
38%
+ Follow
#3
Douglas Tsao
HC Wainwright & Co. · Rank #212
Buy
$16.00+487.2% to target
Overall win rate
35%
+ Follow
#4
Derek Archila
Wells Fargo · Rank #350
Hold
$4.00+46.8% to target
Overall win rate
32%
+ Follow
#5
GC
Gavin Clark-Gartner
Evercore ISI Group
Hold
$4.00+46.8% to target
Coverage
—
+ Follow
CABA stock forecast FAQ
What is CABA's average 12-month price target?+
The 6 analysts with a live target average $14.83 for Cabaletta Bio Inc over the next 12 months, ranging from a $30.00 high to a $4.00 low.
Is CABA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 6 analyst ratings, 5 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CABA?+
The Street-high target is $30.00 (Cantor Fitzgerald), and the Street-low is $4.00 (Wells Fargo). The average of all 6 active targets is $14.83.
How many Wall Street analysts cover CABA?+
6 analysts have an active rating on Cabaletta Bio Inc, and 6 firms carry a live 12-month price target.
Who is the most accurate analyst covering CABA?+
Among analysts who currently cover CABA, Yatin Suneja of Guggenheim has the strongest overall Quantellect track record (Rank #28). Their current call is Buy with a $16.00 target.
What is Cabaletta Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-0.31 per share (range $-0.42 – $-0.20) across 5 analysts. Full-year EPS is projected at $-1.34, rising to $-1.42 the following year.
How much revenue is Cabaletta Bio Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading CABA lately?+
As of Jul, 5 of 6 firms rate CABA a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CABA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
